Lenalidomide Dr.Reddy's (Lenalidomide)
lenalidomide 25 mg capsule, 21 · ORAL · PBS code 15104Y
AUTHORITY_REQUIREDWhat it costs
AU$512.99 PBS-determined price per 21 units
Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.
- • First listed on the PBS: 2025-11-01.
- • Repeats: 2.
- • PBS program: HB.
Eligibility criteria for subsidised access
The following is the government's own wording from the PBS Schedule, shown unchanged.
Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1
Untreated multiple myeloma
Triple combination therapy consisting of daratumumab, lenalidomide and dexamethasone
Patient must be undergoing concurrent treatment with daratumumab obtained through the PBS for the treatment of transplant ineligible, newly diagnosed multiple myeloma; AND
Patient must not be undergoing simultaneous treatment with this drug obtained under another PBS listing.
Sponsor: Dr Reddy's Laboratories (Australia) Pty Ltd ABN 16 120 092 408
Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.
Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.